SEC Form 4/A · accession 0001144204-16-078545
TITAN PHARMACEUTICALS INC · TTNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Sunil Bhonsle
Officer — President and CEO · Director
Period of report
Dec 14, 2015
Accepted (ET)
Feb 2, 2016 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910267
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $5.10 | Dec 14, 2015 | A | 90,900 | A | — | Dec 14, 2025 | Common Stock | 90,900 | 90,900 | D |
Explanation of responses
- F1The options vest in 24 equal monthly installments commencing on the grant date.
Remarks
This form amends and restates the previously filed form.